PIRAMAL PHARMA
|
The Current P/S Ratio of PIRAMAL PHARMA is 2.99.
Share Price | ₹205.6 | Jun 02,2025 |
Market Cap | ₹27,328.4 Cr | |
Sales-TTM | ₹9,151.2 Cr | TTM-Consolidated Results |
Price/Sales | 2.99x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹27,328.4 Cr] as on Jun 02,2025
(/) Sales [ ₹9,151.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.99x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '2.99 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA
PS Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2021 averaged 0.81x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 1.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2024 at 2.09x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
PIRAMAL PHARMA | 9,151.2 | 2.99 | 27,328.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.64 | 401,865.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 18.54 | 173,574.0 |
CIPLA LTD | 27,547.6 | 4.31 | 118,710.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.20 | 105,964.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.19 | 104,232.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.11 | 99,618.8 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.02 | 93,474.1 |
LUPIN LTD | 22,707.9 | 3.94 | 89,505.5 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.08 | 65,993.6 |
ABBOTT INDIA LTD | 6,409.2 | 10.17 | 65,158.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.08x |
Max industry PS | 18.54x |
Median industry PS | 4.31x |
Average industry PS | 6.75x |
You may also like the below Video Courses